As of April 2025 Novavax has a market cap of A$1.49 Billion. This makes Novavax the world's 5465th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | A$1.49 B | -29.74% |
2024 | A$2.13 B | 154.79% |
2023 | A$0.83 B | -34.83% |
2022 | A$1.28 B | -91.39% |
2021 | A$14.92 B | 61.62% |
2020 | A$9.23 B | 4919.83% |
2019 | A$0.18 B | -81.68% |
2018 | A$1.00 B | 68.41% |
2017 | A$0.59 B | 25.75% |
2016 | A$0.47 B | -84.75% |
2015 | A$3.10 B | 79.67% |
2014 | A$1.73 B | 44.49% |
2013 | A$1.19 B | 345.13% |
2012 | A$0.26 B | 90.44% |
2011 | A$0.14 B | -46.81% |
2010 | A$0.26 B | -10.53% |
2009 | A$0.29 B | 60.22% |
2008 | A$0.18 B | -21.47% |
2007 | A$0.23 B | -26.58% |
2006 | A$0.32 B | 11.59% |
2005 | A$0.28 B | 72.84% |
2004 | A$0.16 B | -40.54% |
2003 | A$0.28 B | 143.18% |
2002 | A$0.11 B | -82.09% |
2001 | A$0.64 B | 91.52% |
2000 | A$0.33 B | 158.83% |
1999 | A$0.12 B | 238.14% |
1998 | A$38.39 M | -58.35% |
1997 | A$92.18 M | 99.8% |
1996 | A$46.13 M |
On Apr 11th, 2025 the market cap of Novavax was reported to be: